Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals
- PMID: 2767711
- PMCID: PMC1385327
Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals
Abstract
Eosinophilia in peripheral blood is a common phenomenon associated with atopic condition. The present study illustrates the enhanced sensitivity of these eosinophils for formyl-methionyl-leucylphenylalanine (FMLP) and platelet-activating-factor (PAF) (measured as luminol-enhanced chemiluminescence) compared with eosinophils isolated from the peripheral blood of normal individuals. The PAF-induced chemiluminescence, which is peroxidase dependent and of extracellular origin, is inhibited by the PAF antagonist BN52021. The enhanced sensitivity of eosinophils isolated from atopic patients for FMLP and PAF might reflect a 'primed' state of these cells, relevant for the pathogenesis of atopic disease.
Similar articles
-
Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.Biochem Int. 1992 May;26(6):1105-13. Biochem Int. 1992. PMID: 1321621
-
GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.J Immunol. 1993 Nov 1;151(9):4989-97. J Immunol. 1993. PMID: 8409452
-
Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.J Invest Dermatol. 1993 Feb;100(2):137-42. doi: 10.1111/1523-1747.ep12462781. J Invest Dermatol. 1993. PMID: 8429236
-
Eosinophil and neutrophil chemiluminescence in patients with atopic asthma and in healthy subjects.Allergol Immunopathol (Madr). 1993 Mar-Apr;21(2):71-4. Allergol Immunopathol (Madr). 1993. PMID: 8393267
-
Eosinophils in atopic dermatitis.J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1310-7. doi: 10.1016/0091-6749(94)90347-6. J Allergy Clin Immunol. 1994. PMID: 7798571 Review. No abstract available.
Cited by
-
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002. Drugs. 1991. PMID: 1717219 Review. No abstract available.
-
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.J Exp Med. 1995 Jun 1;181(6):2119-27. doi: 10.1084/jem.181.6.2119. J Exp Med. 1995. PMID: 7760001 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical